Suvankar Pal

9.2k total citations · 3 hit papers
108 papers, 3.6k citations indexed

About

Suvankar Pal is a scholar working on Neurology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Suvankar Pal has authored 108 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Neurology, 31 papers in Molecular Biology and 25 papers in Psychiatry and Mental health. Recurrent topics in Suvankar Pal's work include Amyotrophic Lateral Sclerosis Research (40 papers), Parkinson's Disease Mechanisms and Treatments (30 papers) and Prion Diseases and Protein Misfolding (26 papers). Suvankar Pal is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (40 papers), Parkinson's Disease Mechanisms and Treatments (30 papers) and Prion Diseases and Protein Misfolding (26 papers). Suvankar Pal collaborates with scholars based in United Kingdom, Italy and United States. Suvankar Pal's co-authors include К. Ray Chaudhuri, Jing Ming Yeo, Siddharthan Chandran, John Collinge, Briony Waddell, Sharon Abrahams, Vandana Dhawan, Shuna Colville, Jenna M. Gregory and James R. Cameron and has published in prestigious journals such as The Lancet, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Suvankar Pal

99 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies

2016 420 citations Suvankar Pal, Alison J. E. Green et al. profile →
Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data

2019 261 citations Suvankar Pal et al. profile →
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

2021 171 citations Péter Hermann, Jean‐Philippe Brandel et al. profile →

Peers

Countries citing papers authored by Suvankar Pal

Since Specialization

Citations

This map shows the geographic impact of Suvankar Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvankar Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvankar Pal more than expected).

Fields of papers citing papers by Suvankar Pal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvankar Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvankar Pal. The network helps show where Suvankar Pal may publish in the future.

Co-authorship network of co-authors of Suvankar Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Suvankar Pal. A scholar is included among the top collaborators of Suvankar Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suvankar Pal. Suvankar Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Variant Creutzfeldt-Jakob disease in UK children after 27 years of active prospective surveillance 2025 ·Archives of Disease in Childhood ·Christopher Verity, (unknown), (unknown), Anne Marie Winstone, Suvankar Pal	1
2	Impact of apathy over the course of disease in amyotrophic lateral sclerosis 2025 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ratko Radaković, (unknown), (unknown), (unknown), Eneida Mioshi, (unknown), D J Dick, Judith Newton, Shuna Colville, Suvankar Pal, Siddharthan Chandran, Zachary Simmons, Sharon Abrahams	0
3	Perceptions of digital technology use for monitoring health in people living with neurological disorders 2024 ·Journal of the Neurological Sciences ·(unknown), Emily Beswick, (unknown), (unknown), (unknown), (unknown), David Perry, (unknown), Siddharthan Chandran, Suvankar Pal	1
4	Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease 2024 ·Journal of Neurology ·(unknown), (unknown), (unknown), Neil Watson, J. Mackenzie, Alison J. E. Green, David Summers, Marcelo A. Barria, Sohan Seth, Colin Smith, Suvankar Pal	1
5	Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease 2024 ·Journal of Neurology ·Emily Beswick, Alexander Christides, (unknown), (unknown), (unknown), Judith Newton, (unknown), Christine Weaver, Siddharthan Chandran, Suvankar Pal	2
6	Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72 -ALS iPSC-derived microglia contributes to neurodegeneration 2023 ·Science Advances ·Poulomi Banerjee, Arpan R. Mehta, Raja Sekhar Nirujogi, James D. Cooper, (unknown), Jyoti Nanda, James Longden, Karen Burr, Karina McDade, (unknown), (unknown), Judith Newton, David Story, Suvankar Pal, Colin Smith, Dario R. Alessi, Bhuvaneish T. Selvaraj, Josef Priller, Siddharthan Chandran	27
7	A systematic review and narrative analysis of digital speech biomarkers in Motor Neuron Disease 2023 ·npj Digital Medicine ·(unknown), Emily Beswick, (unknown), David Perry, Alice E. Smith, (unknown), Siddharthan Chandran, Oliver Watts, Suvankar Pal	5
8	Non-motor symptoms in motor neuron disease: prevalence, assessment and impact 2023 ·Brain Communications ·Emily Beswick, (unknown), (unknown), Judith Newton, Rachel Dakin, (unknown), Sharon Abrahams, Alan Carson, Siddharthan Chandran, Suvankar Pal	6
9	Development, reliability, validity, and acceptability of the remote administration of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) 2023 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·(unknown), (unknown), Emily Mayberry, Luke Williams, Caroline McHutchison, Judith Newton, Suvankar Pal, Siddharthan Chandran, Sarah E. MacPherson, Sharon Abrahams, (unknown)	9
10	Factors impacting trial participation in people with motor neuron disease 2023 ·Journal of Neurology ·Emily Beswick, (unknown), Judith Newton, Rachel Dakin, Amy Stenson, Sharon Abrahams, Alan Carson, Siddharthan Chandran, Suvankar Pal	4
11	The relationship between social cognitive processes and behavior changes in people with amnestic mild cognitive impairment or dementia using the Edinburgh Social Cognition Test (ESCoT). 2023 ·Neuropsychology ·R. Asaad Baksh, Sarah E. MacPherson, Bonnie Auyeung, Suvankar Pal, Sharon Abrahams	1
12	Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease 2022 ·BMJ Open ·(unknown), Rachel Dakin, J Williamson, Judith Newton, (unknown), Shuna Colville, Maria Stavrou, Jenna M. Gregory, (unknown), Arpan R. Mehta, Jeremy Chataway, Robert Swingler, Richard Parker, Christopher J. Weir, Nigel Stallard, Mahesh Parmar, Malcolm Macleod, Suvankar Pal, Siddharthan Chandran	18
13	A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease 2022 ·Journal of Neurology ·Emily Beswick, (unknown), (unknown), (unknown), Rachel Dakin, Judith Newton, Sharon Abrahams, Alan Carson, Siddharthan Chandran, David Perry, Suvankar Pal	14
14	Sporadic Creutzfeldt–Jakob Disease in the young (50 and below): 10-year review of United Kingdom surveillance 2022 ·Journal of Neurology ·(unknown), (unknown), (unknown), Neil Watson, J. Mackenzie, (unknown), (unknown), Alison J. E. Green, David Summers, Marcelo A. Barria, Colin Smith, Suvankar Pal	7
15	A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis 2021 ·Journal of Neurology ·Emily Beswick, (unknown), (unknown), (unknown), Judith Newton, Alan Carson, Sharon Abrahams, Siddharthan Chandran, Suvankar Pal	29
16	Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol 2021 ·BMJ Open ·Emily Beswick, Stella A. Glasmacher, Rachel Dakin, Judith Newton, Alan Carson, Sharon Abrahams, Siddharthan Chandran, Suvankar Pal	5
17	The importance of ongoing international surveillance for Creutzfeldt–Jakob disease 2021 ·Nature Reviews Neurology ·Neil Watson, Jean‐Philippe Brandel, Alison Green, Péter Hermann, Anna Ladogana, (unknown), J. Mackenzie, Maurizio Pocchiari, Colin Smith, Inga Zerr, Suvankar Pal	76
18	Validation of The Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer’s disease 2021 ·International Journal of Geriatric Psychiatry ·(unknown), Thomas H. Bak, (unknown), Shuna Colville, Suvankar Pal, Sharon Abrahams	9
19	15.33 Phenotype-genotype characterisation of ‘long survivors’ with motor neurone disease in Scotland 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·Danielle Leighton, Judith Newton, David Parry, Shuna Colville, Robert Swingler, Mary Porteous, Timothy J. Aitman, George Gorrie, Siddharthan Chandran, Suvankar Pal	0
20	Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions 2016 ·Molecular and Cellular Probes ·Elaine Cleary, Suvankar Pal, (unknown), David Moore, Robert Swingler, George Gorrie, Laura Stephenson, Shuna Colville, Siddharthan Chandran, Mary Porteous, Jon Warner	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact